Results 31 to 40 of about 494,025 (276)

Immunomodulation in Recurrent Miscarriage [PDF]

open access: yesThe Journal of Obstetrics and Gynecology of India, 2014
There are many etiological factors responsible for recurrent abortions. However, no explanation can be identified in approximately 40-50 % of women with recurrent miscarriage (RM). Several studies demonstrated that successful pregnancy is dependant on shifting of maternal immune response from (proinflammatory) Th1 toward (anti-inflammatory) Th2 ...
openaire   +2 more sources

Levels of thrombin-activatable fibrinolysis inhibitor and platelet-activating factor in recurrent pregnancy loss patients

open access: yesTaiwanese Journal of Obstetrics & Gynecology, 2016
Objective: The aim of this study was to investigate factors associated with thrombosis that may contribute to recurrent pregnancy loss (habitual abortion), specifically differences in serum levels of platelet-activating factor and thrombin-activatable ...
Ayla Eser   +9 more
doaj   +1 more source

Association of thyroid peroxidase antibodies with the rate of first-trimester miscarriage in euthyroid women with unexplained recurrent spontaneous abortion

open access: yesFrontiers in Endocrinology, 2022
BackgroundUnexplained recurrent spontaneous abortion is a serious reproductive problem of unknown etiology. Thyroid peroxidase antibodies (TPO-Ab) may be associated with pregnancy outcomes in unexplained recurrent spontaneous abortion with normal thyroid
Meilan Liu   +12 more
doaj   +1 more source

Selenium levels and recurrent pregnancy loss : is there an association? [PDF]

open access: yes, 2010
Includes abstract.Includes bibliographical references (leaves 58-67).Miscarriage is the commonest complication of pregnancy and affects 12-31% of all conceptions.
Thomas, Viju
core   +1 more source

Tatalaksana Kehamilan G5P1A3 Gravida 10–11 Minggu dengan Riwayat Keguguran Berulang

open access: yesObgynia, 2021
Recurrent miscarriage is the occurrence of miscarriage at least two or more consecutive times at gestational age less than 20 weeks and/or fetal weight less than 500 grams. Three or more miscarriages occur in 1% couples.
Rena Nurita, Ruswana Anwar
doaj   +1 more source

The lncRNA MALAT1 rs619586 G Variant Confers Decreased Susceptibility to Recurrent Miscarriage

open access: yesFrontiers in Physiology, 2019
Cardiovascula disease and recurrent miscarriage have shared risk factors, and some cardiovascular disease-related candidate genes have been confirmed to be associated with recurrent miscarriage.
Di Che   +14 more
doaj   +1 more source

Polycystic ovary syndrome and recurrent pregnancy loss, a review of literature

open access: yesFrontiers in Endocrinology, 2023
ObjectivePCOS is a syndrome of ovarian dysfunction associated with recurrent pregnancy loss. Several correlating factors have been investigated that influence the risk of pregnancy loss in PCOS.
Rosa Wartena, Mushi Matjila
doaj   +1 more source

LLM‐Integrated Human–Robot Interaction System for Microrobots

open access: yesAdvanced Robotics Research, EarlyView.
This paper proposes an LLM‐based control framework for guiding microrobots using human natural language. This framework can convert the natural human speech into safe and executable command sets for reliable navigation in complex environments. The experimental results show high accuracy and robustness in task performance, demonstrating the potential of
Bairong Zhu, Amar Salehi, Tingting Yu
wiley   +1 more source

Obesity—recurrent miscarriage

open access: yes, 2023
Recurrent miscarriage (RM) is defined as the loss of three or more consecutive pregnancies prior to 20 weeks of gestation, though some authors describe RM as two or more consecutive pregnancy losses.
Ramalingam, Mythili, Mythili Ramalingam
core   +1 more source

Engineering Approaches to Modify Immunomodulatory Functions of Mesenchymal Stromal Cells (MSCs): Tissue Regeneration and Clinical Application

open access: yesAdvanced Science, EarlyView.
Mesenchymal stromal cells (MSCs) show promise for treating immune‐related disorders through immunomodulation and tissue regeneration. This review gives a brief overview of current clinical approval of MSC therapies. It also discussed how bioengineering, including genetic modification, biomaterial delivery, extracellular vesicles, and iPSC‐derived MSCs,
Sichen Yang   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy